- Insilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too WSJ
- Early Data Indicates an A.I.-Generated Drug Could Slow Aging The New York Times
- Drug developed for lung disease may slow biological aging in surprising ‘bonus’ Fox News
- Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment Nature
- Insilico's IPF candidate rentosertib shows anti-aging promise FirstWord PHARMA
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь